RxDoctor Payments Data

Melissa Howey

Family · Omaha, NENPI 1194238378

Payments from drug & device makers

$2,881in general payments, 2019–2025

Across 159 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$609
  • Novo Nordisk$302
  • Sumitomo Pharma America, Inc.$277
  • Daiichi Sankyo Inc.$226
  • Bayer$153
  • Organon$149
  • plus $1K from 29 others

What the payments were for

  • Food & beverage$2,881100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,881 in reported general payments places this provider in the 85th percentile of 809 family providers in Nebraska.

See all family providers in Nebraska

Most prescribed under Part D

DrugClaimsCost to plans & patients
DottiEstradiol18$569
ProgesteroneProgesterone, Micronized11$285

Paid to pharmacies, not to this prescriber.

Other family in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →